U.S., Aug. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07757152) titled 'Phase I Clinical Study of ZL-65 Tablet in Healthy Adult Participants in China' on Aug. 05.

Brief Summary: To evaluate the tolerability and safety of a single oral dose of ZL-65 tablets in healthy adult trial participants through dose escalation; and to preliminarily assess the pharmacokinetic and pharmacodynamic characteristics of a single oral dose of ZL-65 tablets.Exploring the impact of food intake on the PK of orally administered ZL-65 tablets in healthy adult trial participants.

Study Start Date: July 23

Study Type: INTERVENTIONAL

Condition: Healthy Participants Study

Intervention: DRUG: This group of participants take ZL...